• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

制备、表征和体内评价用于控制传递抗肥胖剂 N-油酰基乙醇胺的纳米乳剂。

Preparation, characterization and in vivo evaluation of nanoemulsions for the controlled delivery of the antiobesity agent N-oleoylethanolamine.

机构信息

Biocolloid & Fluid Physics Group, Department of Applied Physics, Faculty of Sciences, University of Granada, 18071, Spain.

出版信息

Nanomedicine (Lond). 2014 Dec;9(18):2761-72. doi: 10.2217/nnm.14.35.

DOI:10.2217/nnm.14.35
PMID:24673263
Abstract

UNLABELLED

AIMS

N-oleoylethanolamine (OEA) is a lipid mediator that acts as a satiety factor. The main limiting factor for its administration is its poor water solubility. We designed and characterized new nanoemulsions as delivery system for hydrophobic compounds such as OEA.

MATERIALS & METHODS: The nanoemulsion components and preparation methods were selected in order to achieve the desired final properties. Then, we evaluated the in vivo properties of the nanoemulsions as drug-delivery systems testing the anorectic effects of OEA in rats after both intragastric and intraperitoneal administration. The in vivo toxicity of the nanoemulsions was evaluated after a 3-week treatment.

RESULTS

Nanoemulsions proved to be stable, nontoxic and had no effect on feeding behavior when administered without OEA. The effects of OEA were observable after its oral and parenteral administration with the nanoemulsions to 24-h fasted rats, finding a better efficacy compared with a vehicle containing Tween(®) 20 (Sigma-Aldrich, MO, USA) after oral administration.

CONCLUSION

These results support the efficacy of these nanoemulsions to deliver highly hydrophobic bioactive drugs.

摘要

目的

N-油酰乙醇胺(OEA)是一种作为饱腹感因子的脂类介质。其给药的主要限制因素是其较差的水溶性。我们设计并表征了新的纳米乳剂作为疏水性化合物如 OEA 的递送系统。

材料与方法

选择纳米乳剂的成分和制备方法,以达到所需的最终性质。然后,我们评估了纳米乳剂作为药物递送系统的体内性质,测试了 OEA 在经口和腹腔内给药后对禁食大鼠的厌食作用。在 3 周的治疗后,评估了纳米乳剂的体内毒性。

结果

纳米乳剂被证明是稳定的、无毒的,并且在没有 OEA 时给药不会影响摄食行为。当用纳米乳剂给 24 小时禁食的大鼠经口和腹腔内给药时,OEA 的作用是可观察到的,与含有吐温 20(Sigma-Aldrich,MO,美国)的载体相比,口服给药具有更好的疗效。

结论

这些结果支持这些纳米乳剂能够输送高度疏水性生物活性药物的功效。

相似文献

1
Preparation, characterization and in vivo evaluation of nanoemulsions for the controlled delivery of the antiobesity agent N-oleoylethanolamine.制备、表征和体内评价用于控制传递抗肥胖剂 N-油酰基乙醇胺的纳米乳剂。
Nanomedicine (Lond). 2014 Dec;9(18):2761-72. doi: 10.2217/nnm.14.35.
2
N-oleoylethanolamine - phosphatidylcholine complex loaded, DSPE-PEG integrated liposomes for efficient stroke.负载N-油酰乙醇胺-磷脂酰胆碱复合物、整合DSPE-PEG的高效治疗中风的脂质体
Drug Deliv. 2021 Dec;28(1):2525-2533. doi: 10.1080/10717544.2021.2008058.
3
Parenteral nanoemulsions as promising carriers for brain delivery of risperidone: Design, characterization and in vivo pharmacokinetic evaluation.注射用纳米乳作为利培酮脑部递药的有前途载体:设计、表征和体内药代动力学评价。
Int J Pharm. 2015 Sep 30;493(1-2):40-54. doi: 10.1016/j.ijpharm.2015.07.007. Epub 2015 Jul 21.
4
Integration of phospholipid-complex nanocarrier assembly with endogenous N-oleoylethanolamine for efficient stroke therapy.磷脂复合物纳米载体组装与内源性 N-油酰乙醇胺的整合用于有效的中风治疗。
J Nanobiotechnology. 2019 Jan 19;17(1):8. doi: 10.1186/s12951-019-0442-x.
5
Food intake is inhibited by oral oleoylethanolamide.口服油酰乙醇胺会抑制食物摄入。
J Lipid Res. 2004 Jun;45(6):1027-9. doi: 10.1194/jlr.C300008-JLR200. Epub 2004 Apr 1.
6
Role of oleoylethanolamide as a feeding regulator in goldfish.油酰乙醇胺作为金鱼进食调节因子的作用
J Exp Biol. 2014 Aug 1;217(Pt 15):2761-9. doi: 10.1242/jeb.106161. Epub 2014 May 22.
7
Oleoylethanolamide inhibits food intake in free-feeding rats after oral administration.口服后,油酰乙醇胺可抑制自由进食大鼠的食物摄入量。
Pharmacol Res. 2004 May;49(5):461-6. doi: 10.1016/j.phrs.2003.12.006.
8
"To brain or not to brain": evaluating the possible direct effects of the satiety factor oleoylethanolamide in the central nervous system.“大脑,还是不大脑”:评估饱食因子油酰乙醇酰胺在中枢神经系统中可能产生的直接作用。
Front Endocrinol (Lausanne). 2023 May 10;14:1158287. doi: 10.3389/fendo.2023.1158287. eCollection 2023.
9
Pharmacological characterization of hydrolysis-resistant analogs of oleoylethanolamide with potent anorexiant properties.具有强效厌食特性的油酰乙醇胺抗水解类似物的药理学特性
J Pharmacol Exp Ther. 2006 Aug;318(2):563-70. doi: 10.1124/jpet.106.105221. Epub 2006 May 15.
10
Oleylethanolamide impairs glucose tolerance and inhibits insulin-stimulated glucose uptake in rat adipocytes through p38 and JNK MAPK pathways.油酰乙醇胺通过p38和JNK丝裂原活化蛋白激酶途径损害大鼠脂肪细胞的葡萄糖耐量并抑制胰岛素刺激的葡萄糖摄取。
Am J Physiol Endocrinol Metab. 2005 Nov;289(5):E923-9. doi: 10.1152/ajpendo.00555.2004. Epub 2005 May 10.

引用本文的文献

1
N-oleoylethanolamine - phosphatidylcholine complex loaded, DSPE-PEG integrated liposomes for efficient stroke.负载N-油酰乙醇胺-磷脂酰胆碱复合物、整合DSPE-PEG的高效治疗中风的脂质体
Drug Deliv. 2021 Dec;28(1):2525-2533. doi: 10.1080/10717544.2021.2008058.
2
Palmitoleoylethanolamide Is an Efficient Anti-Obesity Endogenous Compound: Comparison with Oleylethanolamide in Diet-Induced Obesity.棕榈油酸乙醇酰胺是一种高效的抗肥胖内源性化合物:与饮食诱导肥胖中的油酰乙醇酰胺的比较。
Nutrients. 2021 Jul 28;13(8):2589. doi: 10.3390/nu13082589.
3
Integration of phospholipid-complex nanocarrier assembly with endogenous N-oleoylethanolamine for efficient stroke therapy.
磷脂复合物纳米载体组装与内源性 N-油酰乙醇胺的整合用于有效的中风治疗。
J Nanobiotechnology. 2019 Jan 19;17(1):8. doi: 10.1186/s12951-019-0442-x.